NPS PHARMACEUTICALS INC
NPSP
NPSP was delisted on the 20th of February, 2015.
200 hedge funds and large institutions have $2.61B invested in NPS PHARMACEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 82 increasing their positions, 69 reducing their positions, and 44 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 69
3% less call options, than puts
Call options by funds: $73.7M | Put options by funds: $76.2M
7% less funds holding
Funds holding: 215 → 200 (-15)
22% less capital invested
Capital invested by funds: $3.36B → $2.61B (-$750M)
30% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 44
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$59.3M |
| 2 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$33.8M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$31.3M |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$29.8M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$22.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$93.9M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$45.8M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$42.6M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$20.7M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$20.1M |
NPSP Hedge Fund Activity: Q3 2014 in Review
200 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q3 2014, worth a combined $2.61B — down 22% from $3.36B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of NPSP and 31 opened new positions — a net loss of 13 holders — while 69 trimmed existing stakes and 82 added.
The largest buyer was OrbiMed, adding an estimated $59.3M. The largest seller was Oak Ridge Investments, exiting entirely with an estimated $93.9M sold.
- 200 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q3 2014, down from 215 in Q2 2014.
- Funds reported $2.61B of NPS PHARMACEUTICALS INC stock for Q3 2014, down 22% quarter-over-quarter.
- 31 funds opened new NPS PHARMACEUTICALS INC positions in Q3 2014 and 44 closed out, a net change of -13 holders.
- The largest NPS PHARMACEUTICALS INC buyer in Q3 2014 was OrbiMed, an estimated $59.3M added.
- The largest NPS PHARMACEUTICALS INC seller in Q3 2014 was Oak Ridge Investments, an estimated $93.9M sold.
Based on aggregated 13F filings for Q3 2014.